
|Articles|September 18, 2016
Orphan Drug Cost Controversy Highlights AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
2
Beyond the Transplant Center: IV Therapy in the Community
3
Incorporating Patient-Reported Symptoms into Treatment Plans
4
Safety Monitoring Protocols During Transitions of Care
5


































































































